Last reviewed · How we verify
Benzocaine spray
At a glance
| Generic name | Benzocaine spray |
|---|---|
| Also known as | 20% Benzocaine |
| Sponsor | TC Erciyes University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery (PHASE4)
- Cryotherapy as a Topical Anesthetic in Healthy Children (PHASE4)
- Effects of Topical Lidocaine and Benzocaine on Pain Level and Injection Satisfaction (PHASE3)
- Efficacy Study of Dexmedetomidine Nasal Spray Combined With Propofol for Deep Sedation in ERCP (NA)
- Oral-Spray Bacillus Spore Probiotic in Preventing and Supporting Treatment of Dental Caries in Children (NA)
- Effect of Perineal Cryotherapy on Episiotomy (NA)
- N Acetylcystene in Treatment of Radiotherapy Induced Oral Mucositis in Oral Cancer Patients (NA)
- Intrauterine Device Insertion Pain Management (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Benzocaine spray CI brief — competitive landscape report
- Benzocaine spray updates RSS · CI watch RSS
- TC Erciyes University portfolio CI